Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP719632.RAyxpa6RLn0bnJzupqxI1WJhChntdz-54nQH_nQQQb4_g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP719632.RAyxpa6RLn0bnJzupqxI1WJhChntdz-54nQH_nQQQb4_g130_assertion type Assertion NP719632.RAyxpa6RLn0bnJzupqxI1WJhChntdz-54nQH_nQQQb4_g130_head.
- NP719632.RAyxpa6RLn0bnJzupqxI1WJhChntdz-54nQH_nQQQb4_g130_assertion description "[This is the first study showing the beneficial effect of combining 17-AAG and ritonavir and our data suggest that HSF-1 may be a novel therapeutic target in the treatment of renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719632.RAyxpa6RLn0bnJzupqxI1WJhChntdz-54nQH_nQQQb4_g130_provenance.
- NP719632.RAyxpa6RLn0bnJzupqxI1WJhChntdz-54nQH_nQQQb4_g130_assertion evidence source_evidence_literature NP719632.RAyxpa6RLn0bnJzupqxI1WJhChntdz-54nQH_nQQQb4_g130_provenance.
- NP719632.RAyxpa6RLn0bnJzupqxI1WJhChntdz-54nQH_nQQQb4_g130_assertion SIO_000772 22470109 NP719632.RAyxpa6RLn0bnJzupqxI1WJhChntdz-54nQH_nQQQb4_g130_provenance.
- NP719632.RAyxpa6RLn0bnJzupqxI1WJhChntdz-54nQH_nQQQb4_g130_assertion wasDerivedFrom befree-20140225 NP719632.RAyxpa6RLn0bnJzupqxI1WJhChntdz-54nQH_nQQQb4_g130_provenance.
- NP719632.RAyxpa6RLn0bnJzupqxI1WJhChntdz-54nQH_nQQQb4_g130_assertion wasGeneratedBy ECO_0000203 NP719632.RAyxpa6RLn0bnJzupqxI1WJhChntdz-54nQH_nQQQb4_g130_provenance.